&lt;p&gt;In this episode, Dr. Osterholm and Chris Dall discuss national and international COVID trends, a study on metformin and long COVID incidence, and the use of N95 respirators for protection against wildfire smoke. Dr. Osterholm also answers a COVID query on booster doses and shares a moment of joy from one of our listeners.&lt;/p&gt;
&lt;ul&gt;
	&lt;a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00299-2/fulltext"&gt;Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial&lt;/a&gt;&amp;nbsp;(Bramante et al.,&amp;nbsp;&lt;em&gt;Lancet Infectious Disease&lt;/em&gt;)&lt;br&gt;
	&lt;a href="https://www.cidrap.umn.edu/support"&gt;Support this podcast and our podcast team!&lt;/a&gt;
&lt;/ul&gt;

Episode 134: Good News

A weekly report on the COVID-19 pandemic from infectious disease expert Michael Osterholm, PhD, MPH. Dr. Osterholm is the director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and has spent a career investigating outbreaks. Since 2005, he has emphasized supply chain and other vulnerabilities and a critical need for pandemic preparedness. In this podcast, Dr. Osterholm dissects the latest COVID-19 news, data, and guidance.
CIDRAP’s Chris Dall, MA, is the cohost of the Osterholm Update and a reporter for CIDRAP News. http://www.cidrap.umn.edu